This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

reputable news agency


Hemoglobin glycation index is novel risk factor for incident CKD

Hemoglobin glycation index is novel risk factor for incident CKD

Hemoglobin glycation index (HGI) is a novel risk factor for incident chronic kidney disease (CKD) in the general population, according to a study published online Nov. 1 in the Journal of Clinical Endocrinology & Metabolism.

Yasuto Nakasone, M.D., from the Aizawa Hospital in Matsumoto, Japan, and colleagues examined the impact of HGI as a predictor for incident CKD in the general population in a study using data from 23,467 CKD-free individuals followed for a mean of 5.1 years.

The researchers found that CKD developed in 2,540 individuals, and following low estimated (eGFR), HGI was the second most robust predictor for CKD. The hazard ratio of HGI for CKD was 1.293 after adjustment for 11 covariates, including age, , and eGFR. The population-attributable risk for HGI was 4.2 percent for CKD. In a subgroup of 708 individuals who were propensity scores matched in a 1:1 ratio for nine covariates, HGI was significantly increased in individuals with CKD (median, −0.208 versus −0.284).

"Up to now, we have had only limited tools to predict future CKD for individuals who do not suffer from conventional risk factors, such as diabetes and hypertension," the authors write. "From this point of view, the 4.2 percent is not a small figure, because the denominator is the apparently healthy ."

More information: Yasuto Nakasone et al, Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population, The Journal of Clinical Endocrinology & Metabolism (2023). DOI: 10.1210/clinem/dgad638

Copyright © 2023 HealthDay. All rights reserved.

Citation: Hemoglobin glycation index is novel risk factor for incident CKD (2023, November 21) retrieved 4 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

eGFR variability linked to all-cause mortality risk


Feedback to editors